The Canadian class-action case contains similar allegations to those contained in American lawsuits consolidated in the multidistrict litigation before a federal judge in Illinois.
Bayer has confirmed its Feb. 28, 2013 annual report****** that many of these U.S. cases are in the process of being settled.
"As of February 12, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 4,800 claimants in the U.S. for a total amount of about US $1 billion," according to the annual report.
Bayer also has agreed******* to pay up to $24 million to settle other lawsuits involving allegations over gall bladder side effects, according to the court files in the litigation.
These settlements are a different component of this consolidated litigation in Illinois in which plaintiffs claimed that they suffered gall bladder injuries because they used Yaz and Yasmin as contraceptives.
Reuters News Service reported******* March 20, 2013 that the settlements also include Yaz and Yasmin cases in state courts in California, New Jersey and Pennsylvania.
"Under the agreement, Bayer will pay $2,000 to plaintiffs who suffered gallbladder injuries and $3,000 to individuals who had their gallbladders removed, according to the agreement," Reuters reported.
Women who have filed Yaz and Yasmin blood-clotting lawsuits have claimed that they suffered blood clots, deep vein thrombosis, strokes and pulmonary embolisms as a result of their use of the contraceptives according to allegations contained in their lawsuits.*****
The April 10, 2012 Food and Drug Administration warning about Yaz and Yasmin blood-clotting side effects mirrored these allegations:
“The U.S. Food and Drug Administration (FDA) has completed its review of recent observational (epidemiolog
Copyright©2012 Vocus, Inc.
All rights reserved